CHLAMYDIA PNEUMONIAE IGM ANTIBODIES

Chlamydia pneumoniae IgM Antibodies

What it is

The Chlamydia pneumoniae IgM Antibodies test measures IgM class antibodies in the blood directed against Chlamydia pneumoniae, a bacterium that causes respiratory infections such as pneumonia, bronchitis, and sinusitis. IgM antibodies are the first to appear in response to infection, making this test useful for detecting acute or recent infection.

Uses

This test is used to help diagnose an active or recent Chlamydia pneumoniae infection. It is particularly helpful in distinguishing new infection from past exposure (which is typically reflected by IgG antibodies). The test is often ordered together with IgA and IgG antibody tests or molecular PCR testing for comprehensive evaluation.

Symptoms That May Lead to the Test

Doctors may order this test if you present with symptoms such as persistent cough, fever, sore throat, wheezing, chest pain, or shortness of breath. It is also considered in cases of suspected atypical pneumonia, recurrent bronchitis, or unexplained respiratory illness not responding to standard therapy.

Abnormal Results

Positive IgM: Indicates a current or very recent Chlamydia pneumoniae infection. Since IgM is an early antibody, it suggests the infection is in its acute phase.

Negative IgM: Suggests no evidence of recent infection. However, if symptoms are present, repeat testing or additional IgA/IgG or PCR testing may be needed, as IgM levels decline within weeks after infection.

Risks

The test requires a simple blood sample, with minimal risks such as mild bruising, slight pain, or dizziness at the puncture site. These side effects are rare and temporary.